Misplaced Pages

Talk:Biosafety level: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 16:27, 28 December 2011 editSineBot (talk | contribs)Bots2,555,318 editsm Signing comment by 109.149.157.19 - ""← Previous edit Revision as of 02:59, 29 December 2011 edit undoMiszaBot I (talk | contribs)234,552 editsm Archiving 2 thread(s) (older than 14d) to Talk:Biosafety level/Archive 1.Next edit →
Line 12: Line 12:


This doesn't make much sense. What's considered a neutral to warm zone? The staff, the workplace, the safety level, the agent? And there is no explanation of what neutral to warm is. If it's referencing the safety level, level three is not going to be neutral, that'd make level 1 minus neutral, somehow. <span style="font-size: smaller;" class="autosigned">— Preceding ] comment added by ] (]) 16:26, 28 December 2011 (UTC)</span><!-- Template:Unsigned IP --> <!--Autosigned by SineBot--> This doesn't make much sense. What's considered a neutral to warm zone? The staff, the workplace, the safety level, the agent? And there is no explanation of what neutral to warm is. If it's referencing the safety level, level three is not going to be neutral, that'd make level 1 minus neutral, somehow. <span style="font-size: smaller;" class="autosigned">— Preceding ] comment added by ] (]) 16:26, 28 December 2011 (UTC)</span><!-- Template:Unsigned IP --> <!--Autosigned by SineBot-->

== Private BSL-3 facilities abound ==

Having worked and consulted in the DC area, RTP, Chicago, and at corporate sites around the eastern half of the US, I don't see any way to reasonably assemble a complete list of BSL-3 facilities. None of the ones I've worked at except USAMRIID are on this list; BSL-3 facilities are simply too common. Many vaccine manufacturing and testing facilities exist that can handle the pathogens requiring BSL-3, and most of them are not publicly advertised. The key point for BSL-3 is that treatment exists; if the treatment is derived from the living pathogen, industry will need this facility. While there isn't a West nile, Anthrax, SARS, or yellow fever testing facility on every corner, they are not uncommon enough to have the scarcity noted.

] (]) 16:51, 20 April 2011 (UTC)
TWM

Similarly having worked in the UK industry designing such facilities, there are BSL-3 labs everywhere, and many, many are omitted from the list. BSL-4 is a different beast altogether and are much scarcer! --] (]) 11:24, 3 September 2011 (UTC)

I agree. BSL-3 labs are everywhere and not particularly notable. I added some information from a a 2007 GAO report, showing there were 1356 CDC/USDA registered BSL3 facilities in the US at that time, but only 15 BSL-4. I would recommend that we delete the BSL-3's from the table. ] (]) 21:18, 9 December 2011 (UTC)

== REDACTED ==

My apologies, I was wrong. Nevermind! ] (]) 16:51, 21 August 2011 (UTC)


== Noguchi Memorial Institute for Medical Research == == Noguchi Memorial Institute for Medical Research ==

Revision as of 02:59, 29 December 2011

This is the talk page for discussing improvements to the Biosafety level article.
This is not a forum for general discussion of the article's subject.
Article policies
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL
Archives: 1Auto-archiving period: 14 days 
WikiProject iconMedicine C‑class Low‑importance
WikiProject iconThis article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Misplaced Pages talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
CThis article has been rated as C-class on Misplaced Pages's content assessment scale.
LowThis article has been rated as Low-importance on the project's importance scale.

Laboratory personnel have specific training in handling pathogenic and potentially lethal agents, and are supervised by competent scientists who are experienced in working with these agents. This is considered a neutral or warm zone.

This doesn't make much sense. What's considered a neutral to warm zone? The staff, the workplace, the safety level, the agent? And there is no explanation of what neutral to warm is. If it's referencing the safety level, level three is not going to be neutral, that'd make level 1 minus neutral, somehow. — Preceding unsigned comment added by 109.149.157.19 (talk) 16:26, 28 December 2011 (UTC)

Noguchi Memorial Institute for Medical Research

Revision 456170207 by 197.255.96.5 (talk) added "Noguchi Memorial Institute for Medical Research" (NMIMR) to the External links section, but without any external link, citation, or indication of biosafety levels. I'm moving it to this talk page until the BSL can be confirmed.

The institute is in Ghana, is named after Hideyo Noguchi, and apparently has a BSL-2 or BSL-3 laboratory, or both. Some references:

85.23.32.64 (talk) 14:36, 20 November 2011 (UTC)

Missing BSL-3 Site

The Biosecurity Research Institute at Kansas State University in Manhattan Kansas has a BSL-3, ABSL-3 (animal BSL-3), BSL-3E (Enhanced BSL-3) and BSL-3Ag facility. It is located next to where the new BSL-4 facility is being built. It is mentioned in the article on the new facility but not listed as having its own BSL-3. This information was gleaned from a job posting on their website. So I assume it is reasonably accurate. DJBostrom (talk) 18:42, 3 December 2011 (UTC)

Genetically modified organisms are BSL-2?

Does anyone have a reference for the claim that "Genetically modified organisms have also been classified as level 2 organisms"? Seems like most iGEM projects are being done in BSL-1 labs. Patrikd (talk) 08:24, 9 December 2011 (UTC)

I deleted this statement, since it was clearly incorrect. According to the CDC, the NIH Guidelines are the key reference in assessing risk and establishing an appropriate biosafety level for work involving recombinant DNA molecules: http://oba.od.nih.gov/oba/rac/Guidelines/NIH_Guidelines.htm Patrikd (talk) 21:56, 9 December 2011 (UTC)

Categories: